"Patient and Provider Protection Act."

Summary

The bill forces carriers and their contracted pharmacy benefit managers (PBMs) to create pharmacy‑and‑therapeutics committees that meet strict conflict‑of‑interest standards and to keep higher‑cost drugs from being placed ahead of cheaper generics or biosimilars. It also treats PBM payments as administrative costs, mandates flat‑fee (no commission) arrangements, and requires detailed actuarial disclosures. These changes aim to lower drug costs for patients and increase transparency for insurers.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share